NCT00801294 - A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2006

Primary Completion Date

November 1, 2007

Conditions

Colorectal Neoplasms

Interventions

DRUG

BIBF 1120 and BIBW 2992

Trial Locations (24)

1239.2.3305A clinique Saint Jean, Lyon

1239.2.3305B Cabinet Médical, Lyon

1239.2.3301A Hôpital Saint Antoine, Paris

1239.2.3301B Hôpital Saint Antoine, Paris

1239.2.3301C Hôpital Saint Antoine, Paris

1239.2.3301D Hôpital Saint Antoine, Paris

1239.2.3301E Hôpital Saint Antoine, Paris

1239.2.3301F Hôpital Saint Antoine, Paris

1239.2.3301G Hôpital Saint Antoine, Paris

1239.2.3301H Hôpital Saint Antoine, Paris

1239.2.3301I Hôpital Saint Antoine, Paris

1239.2.3301J Hôpital Saint Antoine, Paris

1239.2.3301K Hôpital Saint Antoine, Paris

1239.2.3302A Hôpital Tenon, Paris

1239.2.3302B Hôpital Tenon, Paris

1239.2.3304A Hôpital Robert Debré, Reims

1239.2.3304B Hôpital Robert Debré, Reims

1239.2.3304C Hôpital Robert Debré, Reims

1239.2.3303A Institut Gustave Roussy, Villejuif

1239.2.3303B Institut Gustave Roussy, Villejuif

1239.2.3303C Institut Gustave Roussy, Villejuif

1239.2.3303D Institut Gustave Roussy, Villejuif

1239.2.3303E Institut Gustave Roussy, Villejuif

1239.2.3303F Institut Gustave Roussy, Villejuif